drugset / Trial / NCT01109693

Strategic Use of New Generation Antidepressants for Depression

NCT01109693

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to establish the optimum treatment strategy for first-line and second-line antidepressants in the acute phase treatment of major depression.

Timeline

Start
2010-12
Primary completion
2015-09
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 15 mg
Comparator Mirtazapine Other / unclassified 45 mg
Comparator Sertraline Small molecule 50 mg
Comparator Sertraline Small molecule 100 mg